Recent studies published in 'Nature' and 'Science' reveal new mechanisms used by the influenza virus to enhance its lethality by hijacking molecules from infected body cells to facilitate its replication. These discoveries open new avenues for understanding how viruses spread and affect human health.
The first human infection with the H9N2 bird flu virus has been reported in Europe, raising concerns among health authorities. Experts emphasize the need for ongoing surveillance to mitigate potential risks.
GSK has opened Spain's first BSL-4 biosecurity laboratory in Tres Cantos, designed to handle dangerous pathogens without available vaccines or effective treatments. The facility employs a team of seven trained researchers, five of whom are women.